NASDAQ:APDN Applied DNA Sciences (APDN) Stock Forecast, Price & News $1.26 -0.06 (-4.55%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$1.23▼$1.3350-Day Range$1.23▼$1.8652-Week Range$0.97▼$3.20Volume28,880 shsAverage Volume36,993 shsMarket Capitalization$17.21 millionP/E RatioN/ADividend YieldN/APrice Target$3.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Applied DNA Sciences MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside177.8% Upside$3.50 Price TargetShort InterestHealthy2.32% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.86) to ($0.68) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.97 out of 5 starsIndustrial Products Sector123rd out of 177 stocksMiscellaneous Business Services Industry4th out of 5 stocks 3.5 Analyst's Opinion Consensus RatingApplied DNA Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.50, Applied DNA Sciences has a forecasted upside of 177.8% from its current price of $1.26.Amount of Analyst CoverageApplied DNA Sciences has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.32% of the outstanding shares of Applied DNA Sciences have been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently decreased by 19.04%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldApplied DNA Sciences does not currently pay a dividend.Dividend GrowthApplied DNA Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for APDN. Previous Next 0.9 News and Social Media Coverage News SentimentApplied DNA Sciences has a news sentiment score of -0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Industrial Products companies.News Coverage This WeekMarketBeat has tracked 1 news article for Applied DNA Sciences this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for APDN on MarketBeat in the last 30 days. This is a decrease of -79% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.83% of the stock of Applied DNA Sciences is held by insiders.Percentage Held by InstitutionsOnly 17.34% of the stock of Applied DNA Sciences is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Applied DNA Sciences are expected to grow in the coming year, from ($0.86) to ($0.68) per share.Price to Book Value per Share RatioApplied DNA Sciences has a P/B Ratio of 1.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Applied DNA Sciences (NASDAQ:APDN) StockApplied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR)-based MDx testing services for the Monkeypox virus; and MDx test kits and related supplies, as well as validates pharmacogenetics (PGx) testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, leather, pharmaceuticals, nutraceuticals, and other products; SigNify IF portable DNA readers and SigNify consumable reagent test kits, which offers a front-line solution for supply chain integrity backed with forensic-level molecular tag authentication; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.Read More APDN Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APDN Stock News HeadlinesSeptember 18, 2023 | americanbankingnews.comApplied DNA Sciences (NASDAQ:APDN) Now Covered by StockNews.comSeptember 17, 2023 | americanbankingnews.comApplied DNA Sciences, Inc. (NASDAQ:APDN) Sees Large Drop in Short InterestSeptember 24, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.September 14, 2023 | finance.yahoo.comApplied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value AnimalsSeptember 6, 2023 | finance.yahoo.comApplied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP ProgramsSeptember 6, 2023 | finance.yahoo.comApplied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP ProgramsAugust 29, 2023 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Announces Availability and First Customer Shipment of New Linea IVT Evaluation KitAugust 29, 2023 | finance.yahoo.comApplied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation KitSeptember 24, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.August 24, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Technology Stocks: Autodesk (ADSK), Applied DNA Sciences (APDN)August 23, 2023 | finance.yahoo.comApplied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA ProductionAugust 11, 2023 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate UpdateAugust 11, 2023 | finance.yahoo.comApplied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate UpdateAugust 9, 2023 | benzinga.comEarnings Preview: Applied DNA SciencesAugust 8, 2023 | finance.yahoo.comADT (ADT) Q2 Earnings and Revenues Miss EstimatesAugust 7, 2023 | finance.yahoo.comApplied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023August 4, 2023 | finance.yahoo.com3 Penny Stocks to Buy Before the BreakoutJuly 18, 2023 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry ConferencesJuly 14, 2023 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Applied DNA Sciences (APDN) and Mogo Finance Technology (MOGO)July 13, 2023 | finance.yahoo.comApplied DNA Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT(TM) Platform to Substantially Improve mRNA Manufacturing and Broaden Market ReachJune 8, 2023 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Announces Presentation at Upcoming Healthcare Investor ConferenceJune 8, 2023 | finance.yahoo.comApplied DNA Announces Presentation at Upcoming Healthcare Investor ConferenceMay 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR), Applied DNA Sciences (APDN) and Dermata Therapeutics (DRMA)May 16, 2023 | finance.yahoo.comApplied DNA Sciences, Inc. (NASDAQ:APDN) Q2 2023 Earnings Call TranscriptMay 11, 2023 | msn.comApplied DNA Sciences: Q2 Earnings InsightsMay 11, 2023 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate UpdateMay 11, 2023 | finance.yahoo.comApplied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate UpdateSee More Headlines Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address APDN Company Calendar Last Earnings8/10/2023Today9/24/2023Fiscal Year End9/30/2023Next Earnings (Estimated)12/13/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Miscellaneous business services Sub-IndustryN/A SectorIndustrial Products Current SymbolNASDAQ:APDN CUSIPN/A CIK744452 Webwww.adnas.com Phone(631) 240-8800Fax631-240-8900Employees61Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.50 High Stock Price Forecast$4.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+177.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,270,000.00 Net Margins-43.47% Pretax Margin-43.79% Return on Equity-83.47% Return on Assets-42.24% Debt Debt-to-Equity RatioN/A Current Ratio4.23 Quick Ratio4.14 Sales & Book Value Annual Sales$18.17 million Price / Sales0.95 Cash FlowN/A Price / Cash FlowN/A Book Value$1.08 per share Price / Book1.17Miscellaneous Outstanding Shares13,660,000Free Float12,726,000Market Cap$17.21 million OptionableOptionable Beta0.59 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. James A. Hayward Ph.D. (Age 69)Sc.D., Chairman, Pres & CEO Comp: $1.27MMs. Beth M. Jantzen CPA (Age 47)CPA, Chief Financial Officer Comp: $390kMs. Judith Murrah (Age 65)COO, Chief Information Officer & Sec. Comp: $438.75kMr. Sanjay M. HurryExec. Director of Investor Relations & Corp. CommunicationsMr. Clay Shorrock Esq. (Age 38)J.D., Chief Legal Officer & Exec. Director of Bus. Devel. Mr. Tony BensonManaging Director of EMEAMr. Joseph L. MagnoSales ConsultantMr. Warren PearlsonSales ConsultantMore ExecutivesKey CompetitorsSarcos Technology and RoboticsNASDAQ:STRCFusion Fuel GreenNASDAQ:HTOOWISeKey InternationalNASDAQ:WKEYArt's-Way ManufacturingNASDAQ:ARTWEuro TechNASDAQ:CLWTView All CompetitorsInstitutional OwnershipCitadel Advisors LLCBought 1,000 shares on 8/15/2023Ownership: 0.000%Simplex Trading LLCSold 400 shares on 8/4/2023Ownership: 0.000%AMH Equity LtdBought 333,000 shares on 8/1/2023Ownership: 2.579%View All Institutional Transactions APDN Stock - Frequently Asked Questions Should I buy or sell Applied DNA Sciences stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" APDN shares. View APDN analyst ratings or view top-rated stocks. What is Applied DNA Sciences' stock price forecast for 2023? 1 brokers have issued 1 year target prices for Applied DNA Sciences' stock. Their APDN share price forecasts range from $3.00 to $4.00. On average, they expect the company's stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 177.8% from the stock's current price. View analysts price targets for APDN or view top-rated stocks among Wall Street analysts. How have APDN shares performed in 2023? Applied DNA Sciences' stock was trading at $1.66 at the beginning of 2023. Since then, APDN shares have decreased by 24.1% and is now trading at $1.26. View the best growth stocks for 2023 here. Are investors shorting Applied DNA Sciences? Applied DNA Sciences saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 316,800 shares, a decline of 19.0% from the August 15th total of 391,300 shares. Based on an average daily volume of 178,400 shares, the short-interest ratio is currently 1.8 days. View Applied DNA Sciences' Short Interest. When is Applied DNA Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, December 13th 2023. View our APDN earnings forecast. How were Applied DNA Sciences' earnings last quarter? Applied DNA Sciences, Inc. (NASDAQ:APDN) issued its quarterly earnings data on Thursday, August, 10th. The technology company reported ($0.24) EPS for the quarter, meeting analysts' consensus estimates of ($0.24). The technology company had revenue of $2.92 million for the quarter, compared to the consensus estimate of $3.10 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 83.47% and a negative net margin of 43.47%. During the same quarter last year, the business posted ($0.33) EPS. What is James A. Hayward's approval rating as Applied DNA Sciences' CEO? 2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend. What other stocks do shareholders of Applied DNA Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC). What is Applied DNA Sciences' stock symbol? Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN." Who are Applied DNA Sciences' major shareholders? Applied DNA Sciences' stock is owned by a number of institutional and retail investors. Top institutional shareholders include AMH Equity Ltd (2.58%), Citadel Advisors LLC (0.00%) and Simplex Trading LLC (0.00%). View institutional ownership trends. How do I buy shares of Applied DNA Sciences? Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Applied DNA Sciences' stock price today? One share of APDN stock can currently be purchased for approximately $1.26. How much money does Applied DNA Sciences make? Applied DNA Sciences (NASDAQ:APDN) has a market capitalization of $17.21 million and generates $18.17 million in revenue each year. How can I contact Applied DNA Sciences? Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The official website for the company is www.adnas.com. The technology company can be reached via phone at (631) 240-8800, via email at investor@adnas.com, or via fax at 631-240-8900. This page (NASDAQ:APDN) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied DNA Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.